OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Multiomics
(1)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
LTQ Orbitrap Elite
(1)
Publication Date
2019
(1)
Release Date
2021
(2)
2023
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
APOBEC3A is an Oral Cancer Prognostic Biomarker in Taiwanese Carriers of an APOBEC Deletion Polymorphism
Chen T-W, Lee C-C, Liu H, Wu C-S, Pickering CR, Huang P-J, et al., Nature Communications 8, Article number: 465 (2017) doi:10.1038/s41467-017-00493-9
Oral squamous cell carcinoma is a prominent cancer worldwide, p...
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2019-08-28
|
MSV000084250
|
MassIVE
Cite
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Not available
S-EPMC8252422
|
biostudies-literature
Cite
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Not available
S-EPMC8648748
|
biostudies-literature
Cite
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Not available
S-EPMC10042416
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets